Previous studies found that IUGR results in progressive reduction in Pdx1 levels due to epigenetic silencing, and the increased diabetes incidence in this model could be prevented by treatment in early life with exendin-4 that increases Pdx143,44, suggesting that reduced Pdx1 during development can induce diabetes. Here, PDX1 is linked to fetal growth restriction.